These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19845110)

  • 21. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
    Bradbury R; Champion A; Reid DW
    Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
    Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
    J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventilator-associated pneumonia: role of colonizers and value of routine endotracheal aspirate cultures.
    Joseph NM; Sistla S; Dutta TK; Badhe AS; Parija SC
    Int J Infect Dis; 2010 Aug; 14(8):e723-9. PubMed ID: 20542716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genomic comparisons of multiresistant Pseudomonas aeruginosa isolates obtained from surgical intensive care unit].
    Wang YM; Liu YC; Wan YL; Liu SL; Liu GR; Wang X; Wang QS; Cao XL
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3319-24. PubMed ID: 19257960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality.
    Furtado GH; Bergamasco MD; Menezes FG; Marques D; Silva A; Perdiz LB; Wey SB; Medeiros EA
    J Crit Care; 2009 Dec; 24(4):625.e9-14. PubMed ID: 19592213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.
    Cholley P; Gbaguidi-Haore H; Bertrand X; Thouverez M; Plésiat P; Hocquet D; Talon D
    J Hosp Infect; 2010 Dec; 76(4):316-9. PubMed ID: 20692070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of susceptibility to beta-lactam antimicrobial agents among bacteria isolated from intensive care units.
    Pierson CL; Friedman BA
    Diagn Microbiol Infect Dis; 1992 Feb; 15(2 Suppl):19S-30S. PubMed ID: 1737439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.
    Walkty A; Decorby M; Nichol K; Mulvey MR; Hoban D; Zhanel G;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):217-21. PubMed ID: 18304774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Nicolau DP; Shore E; Palter M; Pepe J; Kuti JL
    J Crit Care; 2010 Mar; 25(1):69-77. PubMed ID: 19427167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is the quantitative antibiogram a reliable epidemiological marker for Pseudomonas aeruginosa infections? Comparison with pulsed field electrophoresis].
    Foissaud V; Perrier-Gros-Claude JD; Rouby Y; Clavier B; Dusseau JY; Thierry J
    Pathol Biol (Paris); 1998 Jun; 46(6):452-8. PubMed ID: 9769881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
    Aloush V; Navon-Venezia S; Seigman-Igra Y; Cabili S; Carmeli Y
    Antimicrob Agents Chemother; 2006 Jan; 50(1):43-8. PubMed ID: 16377665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.